215 related articles for article (PubMed ID: 36269839)
21. Global target mRNA specification and regulation by the RNA-binding protein ZFP36.
Mukherjee N; Jacobs NC; Hafner M; Kennington EA; Nusbaum JD; Tuschl T; Blackshear PJ; Ohler U
Genome Biol; 2014 Jan; 15(1):R12. PubMed ID: 24401661
[TBL] [Abstract][Full Text] [Related]
22. Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes.
Cao H; Urban JF; Anderson RA
Obesity (Silver Spring); 2008 Jun; 16(6):1208-18. PubMed ID: 18388887
[TBL] [Abstract][Full Text] [Related]
23. The mRNA-binding protein Zfp36 is upregulated by β-adrenergic stimulation and represses IL-6 production in 3T3-L1 adipocytes.
Brahma PK; Zhang H; Murray BS; Shu FJ; Sidell N; Seli E; Kallen CB
Obesity (Silver Spring); 2012 Jan; 20(1):40-7. PubMed ID: 21818148
[TBL] [Abstract][Full Text] [Related]
24. ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production.
Hacker C; Valchanova R; Adams S; Munz B
Growth Factors; 2010 Jun; 28(3):178-90. PubMed ID: 20166898
[TBL] [Abstract][Full Text] [Related]
25. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells.
Zhang Z; Guo M; Li Y; Shen M; Kong D; Shao J; Ding H; Tan S; Chen A; Zhang F; Zheng S
Autophagy; 2020 Aug; 16(8):1482-1505. PubMed ID: 31679460
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in the genes encoding members of the tristetraprolin family of human tandem CCCH zinc finger proteins.
Blackshear PJ; Phillips RS; Vazquez-Matias J; Mohrenweiser H
Prog Nucleic Acid Res Mol Biol; 2003; 75():43-68. PubMed ID: 14604009
[TBL] [Abstract][Full Text] [Related]
27. Functional regulation of Zfp36l1 and Zfp36l2 in response to lipopolysaccharide in mouse RAW264.7 macrophages.
Wang KT; Wang HH; Wu YY; Su YL; Chiang PY; Lin NY; Wang SC; Chang GD; Chang CJ
J Inflamm (Lond); 2015; 12():42. PubMed ID: 26180518
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.
Jin WJ; Chen CF; Liao HY; Gong LL; Yuan XH; Zhao BB; Zhang D; Feng X; Liu JJ; Wang Y; Chen GF; Yan HP; He YW
PLoS One; 2012; 7(3):e33356. PubMed ID: 22428029
[TBL] [Abstract][Full Text] [Related]
29. Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS.
Shah S; Mostafa MM; McWhae A; Traves SL; Newton R
J Biol Chem; 2016 Jan; 291(1):110-25. PubMed ID: 26546680
[TBL] [Abstract][Full Text] [Related]
30. ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA.
Nasir A; Norton JD; Baou M; Zekavati A; Bijlmakers MJ; Thompson S; Murphy JJ
PLoS One; 2012; 7(12):e52187. PubMed ID: 23284928
[TBL] [Abstract][Full Text] [Related]
31. The RNA-binding protein tristetraprolin regulates RALDH2 expression by intestinal dendritic cells and controls local Treg homeostasis.
La C; de Toeuf B; Bindels LB; Van Maele L; Assabban A; Melchior M; Smout J; Köhler A; Nguyen M; Thomas S; Soin R; Delacourt N; Li H; Hu W; Blackshear PJ; Kruys V; Gueydan C; Oldenhove G; Goriely S
Mucosal Immunol; 2021 Jan; 14(1):80-91. PubMed ID: 32467605
[TBL] [Abstract][Full Text] [Related]
32. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic β-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression.
Vogel KU; Bell LS; Galloway A; Ahlfors H; Turner M
J Immunol; 2016 Oct; 197(7):2673-2685. PubMed ID: 27566829
[TBL] [Abstract][Full Text] [Related]
33. Tristetraprolin targets Nos2 expression in the colonic epithelium.
Eshelman MA; Matthews SM; Schleicher EM; Fleeman RM; Kawasawa YI; Stumpo DJ; Blackshear PJ; Koltun WA; Ishmael FT; Yochum GS
Sci Rep; 2019 Oct; 9(1):14413. PubMed ID: 31595002
[TBL] [Abstract][Full Text] [Related]
34. ZFP36 protects lungs from intestinal I/R-induced injury and fibrosis through the CREBBP/p53/p21/Bax pathway.
Cao Y; Huang W; Wu F; Shang J; Ping F; Wang W; Li Y; Zhao X; Zhang X
Cell Death Dis; 2021 Jul; 12(7):685. PubMed ID: 34238924
[TBL] [Abstract][Full Text] [Related]
35. ZFP36 promotes VDR mRNA degradation to facilitate cell death in oral and colonic epithelial cells.
Wang X; Ge X; Liao W; Cao Y; Li R; Zhang F; Zhao B; Du J
Cell Commun Signal; 2021 Aug; 19(1):85. PubMed ID: 34380509
[TBL] [Abstract][Full Text] [Related]
36. ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells.
Mai D; Boyce T; Mehta A; Reff J; Scholler J; Sheppard NC; June CH
Sci Rep; 2024 Feb; 14(1):3113. PubMed ID: 38326511
[TBL] [Abstract][Full Text] [Related]
37. A unique C-terminal repeat domain maintains the cytosolic localization of the placenta-specific tristetraprolin family member ZFP36L3.
Frederick ED; Ramos SB; Blackshear PJ
J Biol Chem; 2008 May; 283(21):14792-800. PubMed ID: 18367448
[TBL] [Abstract][Full Text] [Related]
38. Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses.
Wang Q; Ning H; Peng H; Wei L; Hou R; Hoft DF; Liu J
Nat Commun; 2017 Oct; 8(1):867. PubMed ID: 29021521
[TBL] [Abstract][Full Text] [Related]
39. Production and characterization of ZFP36L1 antiserum against recombinant protein from Escherichia coli.
Cao H; Lin R; Ghosh S; Anderson RA; Urban JF
Biotechnol Prog; 2008; 24(2):326-33. PubMed ID: 18302406
[TBL] [Abstract][Full Text] [Related]
40. Tristetraprolin/ZFP36 Regulates the Turnover of Autoimmune-Associated HLA-DQ mRNAs.
Pisapia L; Hamilton RS; Farina F; D'Agostino V; Barba P; Strazzullo M; Provenzani A; Gianfrani C; Del Pozzo G
Cells; 2019 Dec; 8(12):. PubMed ID: 31817224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]